Tilray Inc (TLRY)
$7.46 0.30 (3.87%)
19:59 EDT TLRY Stock Quote Delayed 30 Minutes
Previous Close $7.46
Market Cap -
PE Ratio -
Volume (Avg. Vol.) 5.45M
Day's Range 7.28 - 7.80
52-Week Range 2.43 - 46.25
Dividend & Yield N/A (N/A)
TLRY Stock Predictions, Articles, and Tilray Inc News
- From InvestorPlace
- From the Web
Tesla, Amazon, Dominion Energy, Sea Ltd and Tilray were our top stock trades for Tuesday. So, let's take a closer look at the charts now.
Even after a robust rally in the overall market, Tilray stock still can't harness lasting momentum. I will continue to avoid TLRY stock.
Although Tilray posted some impressive revenue gains, the bottom line is that the company is still losing money, making TLRY stock riskier than you might think.
Tilray thinks a few companies will control 60%-75% of the global cannabis market. Is that good news or bad for TLRY stock?
Although Tilray stock has looked interesting since hitting a sharp low in March, the viability of its long-term trajectory is a huge question mark.
Tilray's earnings are showing signs of modest improvement. However, the balance sheet underlying TLRY stock is not strong enough to support heavy losses for too long.
Since the March 23 bottom, marijuana stocks are performing better than nine out of ten S&P sectors. There's a few things that might be going on here.
TLRY stock is down over 97% in under two years, and there's no stopping the free fall as the company struggles on multiple fronts.
By Joel Baglole
Tilray has promise but near-term volatility should make investors cautious about TLRY stock.
The owners of TLRY stock might be pleasantly surprised to learn that the company is holding up fairly well.
Marijuana stocks are already getting buying interest ahead of the major event
Rotation into small-cap stocks this week is shining a light on beaten-down equities. Here are three of the best-looking trade ideas.
Compared to its innovative peers like Cronos and Canopy Growth, Tilray is destined to fail. That's why investors should avoid TLRY stock now.
Before you decide to buy or sell Tilray stock and move on to another cannabis play, at least take the time to consider three numbers from its quarterly report. I won’t say which way I’m leaning toward Tilray until the end -- the last time I wrote about TLRY in November, I cautioned investors to wait for a catalyst before buying -- but I can say that Tilray’s business isn’t nearly as bad as the headlines suggest.
The cannabis stock enthusiasm on Wall Street went up in smoke. But doesn't mean that TLRY stock is baked. Better days are still possible.
Tilray and Datadog are set to report earnings, while Nvidia and Penn Gaming continue to trade well. So, let's look at a few top stock trades.
The external fund manager backed by Berkshire Hathaway’s Charlie Munger, Li Lu, makes no bones about it when he says ‘The biggest investment risk is not the volatility of prices,<div><a class="permalink" href="https://simplywall.st/stocks/us/real-estate/nasdaq-mays/jw-mays/news/does-j-w-mays-nasdaqmays-have-a-healthy-balance-sheet/">Read More...</a></div>
In 1995, Lloyd Shulman was appointed CEO of J.W. Mays, Inc. (NASDAQ:MAYS). This report will, first, examine the CEO compensation levels in comparison to CEO compensation at companies of similar<div><a class="permalink" href="https://simplywall.st/stocks/us/real-estate/nasdaq-mays/jw-mays/news/is-j-w-mays-inc-nasdaqmays-overpaying-its-ceo/">Read More...</a></div>
If You Had Bought J.W. Mays (NASDAQ:MAYS) Stock Five Years Ago, You’d Be Sitting On A 59% Loss, Today
Statistically speaking, long term investing is a profitable endeavour. But no-one is immune from buying too high. Zooming in on an example, the J.W. Mays, Inc. (NASDAQ:MAYS) share price dropped<div><a class="permalink" href="https://simplywall.st/stocks/us/real-estate/nasdaq-mays/jw-mays/news/if-you-had-bought-j-w-mays-nasdaqmays-stock-five-years-ago-youd-be-sitting-on-a-59-loss-today/">Read More...</a></div>
Navellier RatingsPowered by Portfolio Grader